Skip to content

Panoramic Brain-Organ Metabolic Axis Framework in 18F-FDG PET/CT Imaging of Healthy Individuals: A Retrospective, Correlational Preliminary Clinical Study

Panoramic Brain-Organ Metabolic Axis Framework in 18F-FDG PET/CT Imaging of Healthy Individuals: A Retrospective, Correlational Preliminary Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113176
Enrollment
Unknown
Registered
2025-11-25
Start date
2026-02-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain-organ metabolic axis

Interventions

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have no obvious lesions after undergoing 18F-FDG PET/CT whole-brain and whole-body imaging in our hospital for physical examination or personal reasons; 2. No other general medical history in the recent period (within 6 months); 3. No history of tumors; 4. Aged >= 18 years, regardless of gender; 5. Complete clinical data (including medical history, laboratory tests, imaging reports, etc.); 6. The image quality of 18F-FDG PET/CT imaging meets the analysis requirements (no obvious motion artifacts, uniform radioactive distribution).

Exclusion criteria

Exclusion criteria: 1. Patients with diseases that may significantly affect systemic metabolism, such as severe liver and kidney failure, end-stage malignant tumors, etc.; 2. Patients who have received radiotherapy, chemotherapy, or immunosuppressant therapy; 3. Presence of organic brain lesions (such as cerebral infarction, acute phase of cerebral hemorrhage) or other conditions that interfere with the assessment of brain metabolism; 4. Unqualified image quality (e.g., insufficient resolution, artifacts affecting region recognition); 5. Key information is missing from clinical data (e.g., unrecorded medical history, lack of laboratory test results).

Design outcomes

Primary

MeasureTime frame
relative coefficient;Maximum standardized uptake value;

Secondary

MeasureTime frame
Intraclass Correlation Coefficient;

Countries

China

Contacts

Public ContactDong Mengjie

Peking University Shenzhen Hospital

Dongmengjie@126.com+86 18257173283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026